Pediatric Seizures

Uploaded on

Author: Danielle Cassidy, Pharm.D., BCPS …

Author: Danielle Cassidy, Pharm.D., BCPS
Audience: Third year pharmacy students at University of Colorado School of Pharmacy
Background: describes common causes of seizures, differentiates dosing of antiepileptic drugs in pediatrics vs. adults, common risk factors associated with febrile seizures, treatment of febrile seizures, treatment of status epilepticus (inpatient & outpatient), & how to dispense/counsel parents on the administration of Diastat.

  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Be the first to comment
No Downloads


Total Views
On Slideshare
From Embeds
Number of Embeds



Embeds 0

No embeds

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

    No notes for slide


  • 1. Danielle Cassidy, Pharm.D. Clinical March 24, 2009
  • 2.  Define common causes of seizures. Differentiate dosing of antiepileptic drugs in kids as compared to adults. List risk factors associated with febrile seizures. Define the American Academy of Pediatrics (AAP) Guidelines for treatment of febrile seizures. Identify appropriate treatment of status epilepticus in kids (inpatient and outpatient). Describe how to dispense and counsel a parent on the administration of Diastat.
  • 3.  Adults & Kids  Kids  Partial seizures  Infantile spasms/ West  Complex syndrome  Simple  Febrile seizures  Secondarily  Lennox-Gastaut generalized syndrome  Generalized seizures  Juvenile absence  Absence  Myoclonic absence  Myoclonic  Benign partial epilepsy  Clonic of childhood  Tonic  Juvenile myoclonic  Tonic-clonic epilepsy  Atonic
  • 4.  Neonatal asphyxia Intraventricular hemorrhage Hypoglycemia/hypocalcemia Infection (meningitis, fever) Genetics Medications/ingestion Trauma Metabolic disorders Cranial Tumors Idiopathic
  • 5.  Kids versus Adults  Similarities  Selection based on seizure type  Measure serum drug levels  Monitor for response to therapy and side effects  Differences  Higher doses due to increased hepatic metabolism and volume of distribution  Dosing is based on mg/kg  Multiple formulations available
  • 6.  Sprinkle capsules  Valproic acid  Topiramate Chewable tablets  Carbamazepine  Phenytoin  Lamotrigine
  • 7.  Liquid  Carbamazepine  Ethosuximide  Gabapentin  Levetiracetam  Oxcarbazepine  Phenytoin  Valproic acid  Diazepam /lorazepam /midazolam /clonazepam  Phenobarbital  Felbamate
  • 8.  How is dosing of pediatric antiepileptic medications different as compared to adults?  A) Children are given 50% of the adult dose  B) Children are dosed on mg/m2  C) Children are dosed on mg/kg
  • 9.  Generalized seizure occurring during febrile illness  Ages 6 months to 5 years  Exclusion criteria  Intracranial infections  Severe metabolic disturbances Incidence ~3%
  • 10.  Risk Factors  Winter months  Family history  Daycare attendance  Neurodevelopmental abnormality  Rapid elevation of temperature
  • 11.  Simple  Less than 15 minutes  Generalized features  Single occurrence in 24 hour period Complex  Greater than 15 minutes  Focal features  More than one occurrence in 24 hours
  • 12.  Treatment not recommended for simple febrile seziures Risk vs. Benefit  High potential for medication related side effects  Phenobarbital  Valproic acid  Diazepam  No evidence demonstrating improved long-term outcomes  Very low risk of adverse outcomes
  • 13.  Old/Classic  Single seizure lasting greater than 30 minutes OR  Recurrent seizures lasting more than 30 minutes without full recovery Revised  Single seizure lasting more than 5 minutes OR  Two or more seizures with incomplete recovery of consciousness
  • 14.  Incidence ~1.3-16% Risk Factors  Metabolic abnormalities  Trauma  CNS infections  Hypoxic events  Intracranial tumors  Cerebrovascular diseases  Noncompliance
  • 15.  Initial management  Maintaining vitals  Adequate oxygenation of the brain  Termination of seizure activity  Prevention of seizure reoccurrence
  • 16. Lorazepam IV 0.1 mg/kg 3-10 mins Fosphenytoin IV 20 PE/kg or Phenytoin IV 20mg/kg 20-30 mins Phenobarbital IV 20 mg/kg 60 mins Midazolam, propofol, thiopental, Keppra, or pentobarbital
  • 17.  Infants  Second line therapy: Phenobarbital Out-patient  Rectal diazepam
  • 18.  What is the correct order of medication administration for status epilepticus?  A) Lorazepam, propofol, leviteracitam  B) Fosphenytoin, phenobarbital, leviteracitam  C) Lorazepam, phenobarbital, fosphenytoin  D) Lorazepam, fosphenytoin, phenobarbital
  • 19.  SB is a 3 year old female presenting with new onset seizure activity. POC report SB began having tactile fevers and HA 3 days PTA. Over the weekend, SB was treated with IBU, which would help periodically, but symptoms would return. On day of admit, she went to her PCP, was dx with a viral illness, and sent home.
  • 20.  When SB arrived home, FOC noticed eye deviation to the left, jerking head movements, and teeth gritting. He took her inside and laid her down at which point she was breathing hard and then stopped breathing for 1 minute. He administered 2 rescue breaths which caused her to cough and resume breathing.
  • 21.  SB then started having left arm and left leg jerking. At this point the paramedics arrived and administered diazepam 2 mg x 2 doses. The entire episode lasted for about 5-10 minutes.
  • 22.  What is SB’s likely diagnosis? Upon arrival to TCH the patient is still seizing and the MD asks your advice about what medication to give next. What is your recommendation? Why? Should SB be sent home with abortive therapy? Why?
  • 23.  MK is a 4 year old female (20 kg) with a hx of Lennox-Gastaut syndrome presenting in status epilepticus . MOC reports antiepileptic medication changes by a pediatric neurologist 2 months PTA. MK was well controlled during this time without any breakthroughs seizures. 7 days PTA, MK began experiencing 1 breakthrough seizure per day.
  • 24.  The pediatric neurologist initiated oxcarbazepine with a rapid dose titration schedule. On day of admission MK had 4-5 seizures in the morning, with none lasting more than 5 minutes. In the afternoon, MK continued to experience multiple seizures and POC took her to the ED. She experienced another seizure in the ED, lasting for more than 5 minutes.
  • 25.  MD administered lorazepam 2mg IV. Was the dose of lorazepam appropriate? MK continues seizing despite a second doses of lorazepam. What medication would you recommend next? Why? MK is still seizing after 30 minutes and the MD is considering phenobarbital. What serious side effect(s) are we worried about with this medication?
  • 26.  Conway EE Jr. (2008). Management of seizures and status epilepticus in the PICU. In T. Shanley & J. Zimmerman (Eds.), Current Concepts in Pediatric Critical Care (pp. 59-67). Society of Critical Care Medicine, Mount Prospect, IL. Epilepsy in children. First Consult®. Elsevier Inc., St Louis, MO. 18 February 2008. Available at: Accessed on March 1, 2008. American Academy of Pediatrics: Committee on Quality Improvement, Subcommittee on Febrile Seizures. Practice Parameter: long- term treatment of the child with simple febrile seizures. Pediatrics 1999;103(6):1307-1039. Status epilepticus in children. First Consult®. Elsevier Inc., St Louis, MO. 18 February 2008. Available at: Accessed on March 1, 2008. Behera MK, Rana KS, et al. Status epilepticus in children. MJAFI 2005;61:174-178. American Medical Association: Working Group on status epilepticus. Treatment of convulsive status epilepticus: recommendations of the epilepsy foundation of American’s Working Group on status epilepticus.